clinical research prime

Maternal GBS (Group B Strep)

  • A Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants.

  • Participants will receive study related treatment at no cost and will be compensated for time and travel.

Eligible participants must meet following criteria:

  • Between 24 - 36 weeks gestational age

  • Does not have complications or abnormalities, including but not limited to: preeclampsia, uncontrolled hypertension, or signs of preterm labor